Meet Our Leadership Team

Our leadership team is tirelessly committed to disrupting cancer’s energy by bringing Misetionamide to market.

Clinical Opinion Leaders & Scientific Advisors

LISA GUTTMAN

Head, Clinical Operations

HANS POEHLER

Head, Pharmacology

ALEXANDER SMITH

Head, CMC & Quality

BEN STEINMETZ

Chief Commercial Officer

KATHRYN Martin, PharmD

Head, Scientific & Regulatory

Communications

Duane Sofia, PhD

Head, Non-Clinical Research

Collaborators

+1.610.922.1910

Copyright © 2025 Panavance Therapeutics Inc.

Our Home

About

Resources

Participate